- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06214754
Efficacy and Safety of Intravascular High-pressure Cutting Balloon Catheters for PCI
January 10, 2024 updated by: BrosMed Medical Co., Ltd
A Prospective, Multicenter, Randomized Controlled Clinical Trial of the Efficacy and Safety of Intravascular High-pressure Cutting Balloon Catheters for PCI
The purpose of this study was to evaluate the safety and efficacy of intravascular high-pressure cut balloon catheter compared to cut balloon catheter during PCI, and to support product registration and clinical application.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
168
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Anhui
-
Hefei, Anhui, China
- The First Affiliated Hospital of USTC
-
-
Fujian
-
Xiamen, Fujian, China
- Zhongshan Hospital Affiliated to Xiamen University
-
-
Heilongjiang
-
Daqing, Heilongjiang, China
- Daqing Oilfield General Hospital
-
-
Henan
-
Zhengzhou, Henan, China
- The First Affiliated Hospital of Zhengzhou University
-
-
Hubei
-
Wuhan, Hubei, China
- Renmin Hospital of Wuhan University
-
-
Hunan
-
Changsha, Hunan, China
- Hunan Provincial People's Hospital
-
-
Jiangxi
-
Nanchang, Jiangxi, China
- The Second Affiliated Hospital of Nanchang University
-
Nanchang, Jiangxi, China
- The First Affiliated Hospital of Nanchang University
-
-
Jilin
-
Jilin, Jilin, China
- China-Japan Union Hospital of Jilin University
-
-
Neimenggu
-
Hohhot, Neimenggu, China
- Inner Mongolia Autonomous Region People's Hospital
-
-
Shaanxi
-
Xi'an, Shaanxi, China
- First Affiliated Hospital of the Air Force Medical University
-
-
Sichuan
-
Chengdu, Sichuan, China
- West China Hospital of Sichuan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Be between 18 and 80 years of age (including boundary values) and have a life expectancy of more than 12 months;
- Be able to understand the purpose of the study, voluntarily participate in and sign the informed consent, and be able and willing to accept the follow-up established in this study;
- Ischemic cardiomyopathy with single or multiple coronary artery lesions and diagnostic evidence [e.g., stable angina, unstable angina, or occult ischemia (evidence of myocardial ischemia);
- Investigator is believed that the target atherosclerotic plaque needs to be incised and that predilation (if necessary) can enable the incised balloon to pass through the lesion;
- The presence of coronary artery stenosis confirmed by imaging examination, suitable for percutaneous coronary intervention, coronary vessel stenosis ≥70%; Or ≥50% (visual) with evidence of ischemia, TIMI ≥ level 1;
- The patient had autogenous coronary angiogenesis or restenosis, requiring stent treatment;
- The reference vessel diameter of target lesion was 2.0mm-4.0mm, and the lesion length was ≤20mm;
- When there are multiple lesions that need to be treated, only one in situ coronary lesion is selected as the target lesion, and the non-target lesion must be located on different vascular branches;
Exclusion Criteria:
- Patients with bleeding tendencies, contraindications to antiplatelet and anticoagulant therapy, who are unable to undergo anticoagulant therapy;
- Have had any myocardial infarction within a week;
- People who have an allergic reaction to contrast media or can't take medication
- There was severe renal failure with or without dialysis, glomerular filtration rate (eGFR) <30ml/min/1.73m2 or serum creatinine level >2.0 mg/ dl;
- cardiogenic shock;
- Patients who have received heart transplants;
- Patients who are not eligible for coronary artery bypass surgery;
- The patient had active peptic ulcer or active gastrointestinal bleeding within 1 month before surgery;
- The patient had a stroke or transient ischemic attack within 2 months before surgery;
- Patients in the pregnancy or lactation period;
- Participants are currently participating in any other clinical trial within 1 month prior to the trial;
- Patients deemed unsuitable for inclusion by other investigators;
- Severe calcified lesions and twisted lesions or lesion sites > 45 degrees angled;
- Lesions with significant endometrial tears
- Unprotected left main lesion;
- The contrast showed a blood clot;
- Scaffold fracture lesion;
- Distal stent lesion after stent implantation;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Intravascular high-pressure cutting balloon catheter
|
The subjects underwent immediate coronary angiography after Percutaneous transluminal coronary angioplasty to evaluate the success rate of instruments, and immediate coronary angiography after PCI to evaluate the success rate of clinical treatment
|
Active Comparator: Boston Scientific Corporation
|
The subjects underwent immediate coronary angiography after Percutaneous transluminal coronary angioplasty to evaluate the success rate of instruments, and immediate coronary angiography after PCI to evaluate the success rate of clinical treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Device Procedural Success Rate
Time Frame: immediately after PTCA
|
In the case of balloon dilatation and stenosis, balloon delivery, balloon filling and dilatation, balloon withdrawal pressure retraction and successful balloon retraction can be successfully completed.
After balloon dilatation, residual stenosis of the target lesion is less than 50%
|
immediately after PTCA
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Success Rate
Time Frame: immediately after PCI
|
The residual lumen stenosis of the target lesion after surgery was less than 20%, the TIMI blood flow was grade 3, and there were no Major Adverse Cardiovascular Events during the follow-up period.
MACE included cardiac death, myocardial infarction of the target vessel, or revascularization of the target lesion.
|
immediately after PCI
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 16, 2023
Primary Completion (Actual)
August 22, 2023
Study Completion (Actual)
December 28, 2023
Study Registration Dates
First Submitted
January 10, 2024
First Submitted That Met QC Criteria
January 10, 2024
First Posted (Actual)
January 22, 2024
Study Record Updates
Last Update Posted (Actual)
January 22, 2024
Last Update Submitted That Met QC Criteria
January 10, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BM-839
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients With Atherosclerotic Plaques in the Coronary Arteries That Require Excision
-
Tel-Aviv Sourasky Medical CenterCompletedConsecutive Subjects Who Are Suitable for a Coronary | Angioplasty of de Novo Lesion(s) in Native Coronary | Arteries Should be Screened for Eligibility. | A Total Number of 200 Patients Fulfilling the Selection | Criteria and Willing to Sign the Informed Consent Should | be Enrolled in the...Israel
-
Sheba Medical CenterUnknownTo Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days. | To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor. | To Evaluate the User Experience With a Closed Loop...Israel
-
Saglik Bilimleri UniversitesiRecruitingCovid-19 Positivity Confirmed With PCR Positivity in the Nasopharyngeal Swab | Symptomatic Covid -19 Positive Patients Who Require Hospitalization | Patients Who Did Not Vaccinate Against Covid-19 | Patients Among 20 to 90 Years of Age | Healthy Control Patients of the Same AgeTurkey
-
Baskent University Ankara HospitalUnknownTo Investigate the Incidence and Causes of Awareness During General Anesthesia | To Investigate the of Dreaming During Anesthesia | To Investigate the Intra-operative Experiences of Patients Who Report Awareness | To Investigate the Risk Factors That May be Associated With Awareness | To... and other conditionsTurkey
-
University of ChicagoCompletedTo Assess the Presence of Internal Pudendal Artery Disease in Patients With Erectile Dysfunction Undergoing Coronary AngiographyUnited States
-
TScan Therapeutics, Inc.CompletedIdentify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection | Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA TypesUnited States
Clinical Trials on PCI
-
Charite University, Berlin, GermanyCompletedIschaemic Heart DiseaseGermany
-
Maatschap Cardiologie ZwolleAbbott; Radboudumc Technology Center; Clinical StudiesRecruitingPercutaneous Coronary Revascularisation | Complex Coronary LesionNetherlands
-
ZOLL Circulation, Inc., USACompletedAcute Myocardial InfarctionSlovenia, Poland, Austria, Estonia, Hungary, Serbia, Sweden, United Kingdom
-
Duke UniversityFood and Drug Administration (FDA); Medtronic; Abbott Medical Devices; The Medicines... and other collaboratorsTerminatedPercutaneous Coronary Intervention | Ischemic Symptoms
-
Unity Health TorontoUnknownAcute Myocardial InfarctionCanada
-
Heinrich-Heine University, DuesseldorfPhilips Medical SystemsUnknownCoronary DiseaseGermany
-
General Hospital of Ningxia Medical UniversityUnknownCarcinoma, Small Cell LungChina
-
Göteborg UniversitySahlgrenska University Hospital, SwedenWithdrawnStable Angina PectorisSweden
-
Shenzhen Raysight Intelligent Medical Technology...Shanghai Zhongshan Hospital; West China Hospital; Shenzhen People's HospitalNot yet recruitingMyocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Vascular Disease OcclusiveChina
-
CoreAalst BVRecruitingCoronary Artery DiseaseDenmark, United Kingdom, Belgium, Italy, Hungary